Difficulty: Medium
Average Score: 64%
Practice
Select the drug which reduces cholesterol synthesis in liver, increases expression of LDL receptors on hepatocytes and has been found to reduce mortality due to coronary artery disease
Correct answer
A
Rationale
The correct answer is A) Simvastatin. Simvastatin belongs to a class of drugs known as statins, which work by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver. By reducing cholesterol production, simvastatin also upregulates the expression of LDL receptors on hepatocytes, leading to increased clearance of LDL cholesterol from the bloodstream. This mechanism ultimately helps to lower LDL cholesterol levels and reduce the risk of cardiovascular events, including mortality due to coronary artery disease.
Option B) Nicotinic acid, also known as niacin, primarily works by reducing the production of VLDL cholesterol in the liver and increasing HDL cholesterol levels. While niacin has some lipid-modifying effects, it does not specifically target cholesterol synthesis in the liver or increase LDL receptor expression like simvastatin.
Option C) Probucol is a lipid-lowering agent that primarily works by increasing the clearance of cholesterol-rich particles from the blood. It does not directly inhibit cholesterol synthesis in the liver or enhance LDL receptor expression, so it is not the correct answer.
Option D) Colestipol is a bile acid sequestrant that works by binding bile acids in the intestine, leading to increased excretion of bile acids and cholesterol in the feces. While colestipol can help lower LDL cholesterol levels, it does not directly inhibit cholesterol synthesis in the liver or increase LDL receptor expression like simvastatin.
In an educational context, understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals to make informed decisions when prescribing medications for patients with cardiovascular conditions. Knowing the specific actions of drugs like simvastatin can help healthcare providers tailor treatment plans to effectively manage cholesterol levels and reduce the risk of cardiovascular events in their patients.
Option B) Nicotinic acid, also known as niacin, primarily works by reducing the production of VLDL cholesterol in the liver and increasing HDL cholesterol levels. While niacin has some lipid-modifying effects, it does not specifically target cholesterol synthesis in the liver or increase LDL receptor expression like simvastatin.
Option C) Probucol is a lipid-lowering agent that primarily works by increasing the clearance of cholesterol-rich particles from the blood. It does not directly inhibit cholesterol synthesis in the liver or enhance LDL receptor expression, so it is not the correct answer.
Option D) Colestipol is a bile acid sequestrant that works by binding bile acids in the intestine, leading to increased excretion of bile acids and cholesterol in the feces. While colestipol can help lower LDL cholesterol levels, it does not directly inhibit cholesterol synthesis in the liver or increase LDL receptor expression like simvastatin.
In an educational context, understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals to make informed decisions when prescribing medications for patients with cardiovascular conditions. Knowing the specific actions of drugs like simvastatin can help healthcare providers tailor treatment plans to effectively manage cholesterol levels and reduce the risk of cardiovascular events in their patients.